These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25827401)

  • 21. Generation of an affinity matrix useful in the purification of natural inhibitors of plasmepsin II, an antimalarial-drug target.
    Ramírez AR; Guerra Y; Otero A; García B; Berry C; Mendiola J; Hernández-Zanui A; Chávez Mde L
    Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):149-57. PubMed ID: 18471091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
    Kumar Singh A; Rajendran V; Singh S; Kumar P; Kumar Y; Singh A; Miller W; Potemkin V; Poonam ; Grishina M; Gupta N; Kempaiah P; Durvasula R; Singh BK; Dunn BM; Rathi B
    Bioorg Med Chem; 2018 Jul; 26(13):3837-3844. PubMed ID: 29983285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screening.
    Meissner KA; Kronenberger T; Maltarollo VG; Trossini GHG; Wrenger C
    Chem Biol Drug Des; 2019 Mar; 93(3):300-312. PubMed ID: 30320974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational inhibitor design against malaria plasmepsins.
    Bjelic S; Nervall M; Gutiérrez-de-Terán H; Ersmark K; Hallberg A; Aqvist J
    Cell Mol Life Sci; 2007 Sep; 64(17):2285-305. PubMed ID: 17585371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
    Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
    J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deciphering the mechanism of potent peptidomimetic inhibitors targeting plasmepsins - biochemical and structural insights.
    Mishra V; Rathore I; Arekar A; Sthanam LK; Xiao H; Kiso Y; Sen S; Patankar S; Gustchina A; Hidaka K; Wlodawer A; Yada RY; Bhaumik P
    FEBS J; 2018 Aug; 285(16):3077-3096. PubMed ID: 29943906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful application of virtual screening and molecular dynamics simulations against antimalarial molecular targets.
    Nunes RR; Costa MD; Santos BD; Fonseca AL; Ferreira LS; Chagas RC; Silva AM; Varotti FP; Taranto AG
    Mem Inst Oswaldo Cruz; 2016 Dec; 111(12):721-730. PubMed ID: 27982302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A heterogeneous enzymatic assay for quantification of Plasmepsin II activity and the evaluation of its inhibitors.
    Salas E; Ramírez A; Otero-Bilbao A; Vázquez R; Reyes O; Mendiola J; Duarte CA; Otero-González A; Gutiérrez OA; Chávez MA
    J Pharm Biomed Anal; 2004 Mar; 34(4):833-40. PubMed ID: 15019062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
    Nezami A; Luque I; Kimura T; Kiso Y; Freire E
    Biochemistry; 2002 Feb; 41(7):2273-80. PubMed ID: 11841219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular dynamics simulations of the three dimensional model of plasmepsin II-peptidic inhibitor complexes.
    Pranav Kumar SK; Kulkarni VM
    Drug Des Discov; 2001; 17(4):293-313. PubMed ID: 11765133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts.
    Meyers MJ; Goldberg DE
    Curr Top Med Chem; 2012; 12(5):445-55. PubMed ID: 22242846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of Plasmepsin II-potential antimalarial agents.
    Corminboeuf O; Dunet G; Hafsi M; Grimont J; Grisostomi C; Meyer S; Binkert C; Bur D; Jones A; Prade L; Brun R; Boss C
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6194-9. PubMed ID: 17000102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Aminoquinazolin-4(3H)-one based plasmepsin inhibitors with improved hydrophilicity and selectivity.
    Rasina D; Stakanovs G; Borysov OV; Pantelejevs T; Bobrovs R; Kanepe-Lapsa I; Tars K; Jaudzems K; Jirgensons A
    Bioorg Med Chem; 2018 May; 26(9):2488-2500. PubMed ID: 29636223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
    Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.
    Zogota R; Kinena L; Withers-Martinez C; Blackman MJ; Bobrovs R; Pantelejevs T; Kanepe-Lapsa I; Ozola V; Jaudzems K; Suna E; Jirgensons A
    Eur J Med Chem; 2019 Feb; 163():344-352. PubMed ID: 30529637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a plasmepsin II fluorescence polarization assay suitable for high throughput antimalarial drug discovery.
    Flotow H; Leong CY; Buss AD
    J Biomol Screen; 2002 Aug; 7(4):367-71. PubMed ID: 12230891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents.
    Boss C; Richard-Bildstein S; Weller T; Fischli W; Meyer S; Binkert C
    Curr Med Chem; 2003 Jun; 10(11):883-907. PubMed ID: 12678679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
    Zürcher M; Gottschalk T; Meyer S; Bur D; Diederich F
    ChemMedChem; 2008 Feb; 3(2):237-40. PubMed ID: 17918177
    [No Abstract]   [Full Text] [Related]  

  • 39. New organofluorine building blocks: inhibition of the malarial aspartic proteases plasmepsin II and IV by alicyclic alpha,alpha-difluoroketone hydrates.
    Fäh C; Hardegger LA; Baitsch L; Schweizer WB; Meyer S; Bur D; Diederich F
    Org Biomol Chem; 2009 Oct; 7(19):3947-57. PubMed ID: 19763297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New inhibitors of the malaria aspartyl proteases plasmepsin I and II.
    Dahlgren A; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2003 Aug; 11(16):3423-37. PubMed ID: 12878137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.